Utilising animal models to evaluate oseltamivir efficacy against influenza A and B viruses with reduced in vitro susceptibility

• Rubaiyea Farrukee ,

  Contributed equally to this work with: Rubaiyea Farrukee, Celeste Ming-Kay Tai

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: Rubaiyea.farrukee@influenzacentre.org

  Affiliations WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia, Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia

  http://orcid.org/0000-0001-9023-246X

  ⨯
• Celeste Ming-Kay Tai ,

  Contributed equally to this work with: Rubaiyea Farrukee, Celeste Ming-Kay Tai

  Roles Conceptualization, Investigation, Methodology, Visualization

  Affiliation WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia

  http://orcid.org/0000-0002-5148-8929

  ⨯
• Ding Yuan Oh,

  Roles Conceptualization, Funding acquisition, Investigation, Methodology, Validation, Writing – original draft

  Affiliations WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia, School of Health and Life Sciences, Federation University, Churchill, Victoria, Australia

  ⨯
• Danielle E. Anderson,

  Roles Investigation, Methodology

  Affiliation Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore

  http://orcid.org/0000-0003-4791-5024

  ⨯
• Vithiagaran Gunalan,

  Roles Data curation, Formal analysis, Visualization

  Affiliation Bioinformatics Institute, Agency for Science, Technology and Research, Singapore, Singapore

  ⨯
• Martin Hibberd,

  Roles Resources

  Affiliation Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore

  ⨯
• Gary Yuk-Fai Lau,

  Roles Resources

  Affiliation Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore

  ⨯
• Ian G. Barr,

  Roles Funding acquisition, Project administration, Resources, Supervision, Writing – review & editing

  Affiliations WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia, Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia, School of Health and Life Sciences, Federation University, Churchill, Victoria, Australia

  ⨯
• Veronika von Messling,

  Roles Funding acquisition, Supervision

  Affiliations Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Veterinary Medicine Division, Paul-Ehrlich-Institute, Federal Institute for Vaccines and Biomedicines, Langen, Germany

  http://orcid.org/0000-0002-3972-8723

  ⨯
• Sebastian Maurer-Stroh,

  Roles Funding acquisition, Supervision

  Affiliations Bioinformatics Institute, Agency for Science, Technology and Research, Singapore, Singapore, National Public Health Laboratories, National Centre for Infectious Diseases, Ministry of Health, Singapore, Department of Biological Sciences, National University Singapore, Singapore

  http://orcid.org/0000-0003-0813-9640

  ⨯
• Aeron C. Hurt

  Roles Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – review & editing

  Affiliations WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia, Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia

  ⨯